Mcl-1 is an anti-apoptotic protein that plays a critical role in the development of resistance to anti-cancer drugs, including epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and Bcl-2 inhibitors25. Here, MCL1 is linked to cancer.